REGAIN CONTROL WITH PERSONALIZED MUSCLE REGENERATION
Meet MUVON
Our Story
MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a therapeutic platform for the regeneration of skeletal muscle tissue based on autologous cells, not only repairing damaged tissue but also increasing the regenerative potential of weakened muscles. Our initial area of focus is the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthy life.
Our Vision
MUVON is leading the development of transformative therapies for treating diseases of high unmet medical need caused by muscle damage or degradation to extend the human health-span.
We aim to establish personalized, regenerative treatments as an affordable standard of care, to help the millions of patients suffering from seriously debilitating diseases.
Our Technology
MUVON Therapeutics is developing a novel regenerative therapy platform for the treatment of diseases related to skeletal muscle damage or degradation. Our technology enables the targeted isolation of muscle precursor cells (MPCs) from muscle tissue, the controlled expansion of these cells and the regeneration of muscle tissue through injection of the expanded cells.
Our initial focus is on developing a safe and effective therapy for the treatment of stress urinary incontinence in women, which is currently in Phase II of clinical development.
Supporters
& Partners
Awards
News
